XML 34 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Discontinued Operations
12 Months Ended
Dec. 31, 2020
Discontinued Operations  
Discontinued Operations

9. Discontinued Operations

Magellan Complete Care – Stock and Asset Purchase Agreement

As discussed in Note 1— “General”, on December 31, 2020, the Company completed the sale of its MCC Business to Molina, pursuant to a Stock and Asset Purchase Agreement, dated as of April 30, 2020, by and between the Company and Molina, for cash in the amount of $850 million plus closing adjustments of $158 million (subject to post-closing adjustments, if any), and the assumption by Molina of liabilities of the MCC Business.

In connection with the MCC Sale, the Company and Molina are entering into commercial agreements for certain behavioral health, utilization management and related services to be provided by the Company to Molina and the MCC business. In addition, the parties will enter into a transition services agreement pursuant to which the Company and certain of its affiliates will provide, or cause third parties to provide, certain services to accommodate the transition of the MCC business to Molina.

The foregoing description of the Purchase Agreement and the MCC Sale does not purport to be complete and is qualified in its entirety by the terms and conditions of the Purchase Agreement, which was filed as Exhibit 2.1 to the Company’s Quarterly Report on Form 10-Q which was filed with the SEC on May 11, 2020, and any related agreements.

The accounting requirements for reporting a business to be divested as a discontinued operation were met during the second quarter of 2020. Accordingly, the accompanying consolidated financial statements for all periods presented reflect the MCC business as a discontinued operation.

The following table summarizes the major classes of assets and liabilities held for sale that were included in the Company’s consolidated balance sheets as of December 31, 2019 (in thousands):

December 31, 

2019

    

Assets Held For Sale

Cash and cash equivalents ($95,202 restricted)

$

209,497

Accounts receivable, net

 

209,496

Short-term and long-term investments ($243,496 restricted)

 

243,496

Property and equipment, net

 

6,710

Goodwill

 

211,735

Other intangible assets, net

 

85,669

Other current and long-term assets ($2,387 restricted)

32,386

Total Assets Held For Sale

998,989

Less: current portion

663,276

Total Assets Held For Sale, Less Current Portion

$

335,713

Liabilities Held For Sale

Accounts payable

$

4,625

Accrued liabilities

 

92,170

Medical claims payable

 

281,419

Other medical liabilities

 

31,769

Deferred income taxes

15,063

Tax contingencies

 

5,388

Deferred credits and other long-term liabilities

 

16,850

Total Liabilities Held For Sale

 

447,284

Less: current portion

 

409,983

Total Liabilities Held For Sale, Less Current Portion

$

37,301

The following table summarizes the components of income from discontinued operations that is included in the Company’s consolidated income statements for the years ended December 31, 2018, 2019 and 2020 (in thousands):

    

Year Ended

December 31, 

    

2018

    

2019

    

2020

Managed care and other revenue

$

2,529,386

$

2,757,511

$

2,924,014

Costs and expenses:

Cost of care

 

2,207,721

 

2,397,007

 

2,377,847

Direct service costs and other operating expenses (1)(2)(3)

 

300,696

 

292,351

 

360,783

Depreciation and amortization

 

20,376

 

21,142

 

20,358

Interest expense

 

216

 

285

 

89

Interest and other income

 

(9,184)

 

(12,332)

 

(5,464)

Gain on sale

(348,145)

Total costs and expenses

 

2,519,825

 

2,698,453

 

2,405,468

Income from discontinued operation before income taxes

 

9,561

 

59,058

 

518,546

Provision for income taxes

 

7,556

 

15,753

 

140,257

Net income from discontinued operations

$

2,005

$

43,305

$

378,289

(1)Includes stock compensation expense of $536, $828 and $278 for the years ended December 31, 2018, 2019 and 2020 respectively.
(2)Includes changes in fair value of contingent consideration of $199 and $(2,124) for the years ended December 31, 2018 and 2019, respectively.
(3)Includes divestiture related expenses of $9,379 for the year ended December 31, 2020.

The Company has retained corporate overhead expenses previously allocated to MCC of $35.1 million, $33.6 million and $30.4 million for the years ended December 31, 2018, 2019 and 2020, respectively.